Ileostomy Market: Global Industry Analysis and Forecast (2023-2029)

Ileostomy Market was valued at US$ 1408.07 Mn. in 2022 and the market size is expected to grow at a CAGR of 8.38 % through the forecast period.

Ileostomy Market Overview:

Ileostomy is a technique used to treat disorders with the large intestine that are difficult to treat with standard medications. IBD (inflammatory bowel disease) is a common reason for an ileostomy procedure. IBD is caused by abnormal gut function when it comes to removing waste from the body. Stoma is a procedure that involves creating a hole in the abdominal wall to direct waste. It might be done on a permanent or temporary basis. The report explores the Global Ileostomy Market's segments (Procedure, Disease Indication, End User and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2018 to 2029. The report investigates the Global Ileostomy Market's drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Global Ileostomy Market's contemporary competitive scenario.Ileostomy MarketTo know about the Research Methodology :- Request Free Sample Report 2022 is considered as a base year to forecast the market from 2022 to 2029. 2022’s market size is estimated on real numbers and outputs of the key players and major players across the globe. Past five years' trends are considered while forecasting the market through 2029. 2022 is a year of exception and analysis especially with the impact of lockdown by region.

Ileostomy Market Dynamics:

Ileostomy has a number of technological advantages, including reduced time, minimum use, and standardised results. These processes also have a simple user interface and provide more patient traceability in their approach. Furthermore, the danger of colon cancer has increased in the elderly, with 91 percent of cases detected in those aged 55 and up, and this procedure is used to treat the early indications. Researchers are currently working on improving ileostomy quality control and raising standards, which is fueling the usage of totally end ileostomy techniques that do not require the use of an external bag. Demand for Ileostomy Procedures to Gain Impetus in Ambulatory Surgical Centers: Aside from the primary features of ileostomy bags, customers want skin-friendly, long-lasting, and water-resistant items. As a result of these demands, leading, significant, and rising ileostomy market players are solidifying their market positions by promoting innovative solutions that meet patients' comfort needs. For example, 11Health and Technologies Limited announced the debut of a new device called the Stom-I Alert Sensor, which provides ostomy patients a signal via a mobile app, text message, or email when their stoma bag is full. Another company, Hollister Corporation, has announced the launch of a new stoma bag with a lubricating deodorant to help ostomy sufferers feel more self-assured. Ileostomy Market: Drivers & Restraints The ileostomy technique's commercial expansion is supported by several technical advantages of the system, such as reduced time, limited use, and standardised results. These methods also have a simple interface and provide more traceability in their approach to the patient. Furthermore, the risk of colorectal cancer increases with age, with 91 percent of cases detected in those over 55, and this approach is used to treat the early indications. Researchers are now working to improve ileostomy quality control and raise standards, which is fueling the adoption of totally end ileostomy techniques that do not require the use of an external bag. There are various issues with the current practise of ileostomy in older patients, one of which is weight gain as a result of ageing, which can induce retraction of an intestinal stoma, possibly resulting in pouch fit issues, daily care challenges, and discomfort circling around the routine.

Ileostomy Market Segment Analysis:

Based on Disease Indication, the cancer segment accounted for a major xx% share of the global ileostomy market in 2021. Colorectal cancer necessitates ileostomy procedures, and cancer prevalence is increasing globally. Ileostomy Market1 Based on the End User, The hospitals held major share of the market in 2018 due to various surgical procedures available in the hospitals.

Ileostomy Market Regional Insights:

The Europe region dominated the market with xx% share in 2022. The Asia Pacific and North America region is expected to witness significant growth through the forecast period. The Europe has a well-developed healthcare infrastructure, which has aided the ileostomy market's rise in Europe. North America of its healthcare policies and allocated funds for cancer treatments, it accounts for a large proportion of the market, which is predicted to direct the market in the future years. The objective of the report is to present a comprehensive analysis of the Global Ileostomy Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Global Ileostomy Market dynamic, structure by analyzing the market segments and projecting the Global Ileostomy Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, Procedure portfolio, growth strategies, and regional presence in the Global Ileostomy Market make the report investor’s guide.

Ileostomy Market Scope: Inquire before buying

Global Ileostomy Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US$ 1408.07Mn.
Forecast Period 2023 to 2029 CAGR: 8.38% Market Size in 2029: US$ 2473.25 Mn.
Segments Covered: by Procedure End Ileostomy Loop Ileostomy
by Disease Indication Cancer Ulcerative Colitis Crohn’s Disease Diverticulitis
by End User Hospitals Ambulatory Surgical Centers Clinics

Ileostomy Market by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Ileostomy Market Key Players are:

1. Smith & Nephew 2. Convatec Inc. 3. 3M Healthcare 4. B. Braun Melsungen AG 5. Coloplast 6. Hollister Incorporated 7. Salts Healthcare 8. Flexicare Medical Ltd. 9. Marlen Manufacturing 10.Welland Medical Limited 11.Pelican Healthcare

Frequently Asked Questions:

1] What segments are covered in the Global Ileostomy Market report? Ans. The segments covered in the Global Ileostomy Market report are based on Procedure, Disease Indication and End User. 2] Which region is expected to hold the highest share in the Global Ileostomy Market? Ans. Europe region is expected to hold the highest share in the Global Ileostomy Market. 3] What is the market size of the Global Ileostomy Market by 2029? Ans. The market size of the Global Ileostomy Market by 2029 is expected to reach US$ 2473.25 Mn. 4] What is the forecast period for the Global Ileostomy Market? Ans. The forecast period for the Global Ileostomy Market is 2023-2029. 5] What was the market size of the Global Ileostomy Market in 2022? Ans. The market size of the Global Ileostomy Market in 2022 was valued at US$ 1408.07 Mn.
1. Global Ileostomy Market: Research Methodology 2. Global Ileostomy Market: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Global Ileostomy Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Ileostomy Market: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12. COVID-19 Impact 4. Global Ileostomy Market Segmentation 4.1. Global Ileostomy Market, By Procedure (2022-2029) • End Ileostomy • Loop Ileostomy 4.2. Global Ileostomy Market, By Disease Indication (2022-2029) • Cancer • Ulcerative Colitis • Crohn’s Disease • Diverticulitis 4.3. Global Ileostomy Market, By End-User (2022-2029) • Hospitals • Ambulatory Surgical Centers • Clinics 5. North America Global Ileostomy Market (2022-2029) 5.1. North America Platelet Aggregation Inhibitors Market, By Procedure (2022-2029) • End Ileostomy • Loop Ileostomy 5.2. North America Platelet Aggregation Inhibitors Market, By Disease Indication (2022-2029) • Cancer • Ulcerative Colitis • Crohn’s Disease • Diverticulitis 5.3. North America Platelet Aggregation Inhibitors Market, By End-User (2022-2029) • Hospitals • Ambulatory Surgical Centers • Clinics 5.4. North America Platelet Aggregation Inhibitors Market, by Country (2022-2029) • United States • Canada • Mexico 6. European Global Ileostomy Market (2022-2029) 6.1. European Platelet Aggregation Inhibitors Market, By Procedure (2022-2029) 6.2. European Platelet Aggregation Inhibitors Market, By Disease Indication (2022-2029) 6.3. European Platelet Aggregation Inhibitors Market, By End-User (2022-2029) 6.4. European Platelet Aggregation Inhibitors Market, by Country (2022-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Global Ileostomy Market (2022-2029) 7.1. Asia Pacific Platelet Aggregation Inhibitors Market, By Procedure (2022-2029) 7.2. Asia Pacific Platelet Aggregation Inhibitors Market, By Disease Indication (2022-2029) 7.3. Asia Pacific Platelet Aggregation Inhibitors Market, By End-User (2022-2029) 7.4. Asia Pacific Platelet Aggregation Inhibitors Market, by Country (2022-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Global Ileostomy Market (2022-2029) 8.1. Middle East and Africa Platelet Aggregation Inhibitors Market, By Procedure (2022-2029) 8.2. Middle East and Africa Platelet Aggregation Inhibitors Market, By Disease Indication (2022-2029) 8.3. Middle East and Africa Platelet Aggregation Inhibitors Market, By End-User (2022-2029) 8.4. Middle East and Africa Platelet Aggregation Inhibitors Market, by Country (2022-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Global Ileostomy Market (2022-2029) 9.1. South America Platelet Aggregation Inhibitors Market, By Procedure (2022-2029) 9.2. South America Platelet Aggregation Inhibitors Market, By Disease Indication (2022-2029) 9.3. South America Platelet Aggregation Inhibitors Market, By End-User (2022-2029) 9.4. South America Platelet Aggregation Inhibitors Market, by Country (2022-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1. Smith & Nephew 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Convatec Inc. 10.3. 3M Healthcare 10.4. B. Braun Melsungen AG 10.5. Coloplast 10.6. Hollister Incorporated 10.7. Salts Healthcare 10.8. Flexicare Medical Ltd. 10.9. Marlen Manufacturing 10.10. Welland Medical Limited 10.11. Pelican Healthcare
  • INQUIRE BEFORE BUYING